Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Abstract Background Co-use of stimulants and opioids is rapidly increasing. Randomized clinical trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD), but stimulant use may decrease the likelihood of initiating MOUD treatment. Furthermore, trial participants may n...

Full description

Bibliographic Details
Main Authors: R. R. Cook, C. Foot, O. A. Arah, K. Humphreys, K. E. Rudolph, S. X. Luo, J. I. Tsui, X. A. Levander, P. T. Korthuis
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Addiction Science & Clinical Practice
Subjects:
Stimulants
Methamphetamine
Cocaine
Medications for opioid use disorder
Buprenorphine
Extended-release naltrexone
Online Access:https://doi.org/10.1186/s13722-023-00364-3

Internet

https://doi.org/10.1186/s13722-023-00364-3

Similar Items